Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...
These trials suggest that the rHEV vaccine is safe and can prevent clinically overt acute hepatitis E in high-risk populations. We herein review the different approaches in HEV-vaccine development ...
Preclinical in vivoand in vitrodata show cross-reactivity and cross-protection by A2 vaccines against non-A2 HBV genotypes. The implementation of universal hepatitis vaccination in most countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback